Wave Life Sciences Ltd. (WVE)
NASDAQ: WVE · Real-Time Price · USD
13.42
-0.29 (-2.12%)
Mar 5, 2026, 1:07 PM EST - Market open
Wave Life Sciences Stock Forecast
Stock Price Forecast
The 15 analysts with 12-month price forecasts for Wave Life Sciences stock have an average target of 30.73, with a low estimate of 10 and a high estimate of 50. The average target predicts an increase of 128.99% from the current stock price of 13.42.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Wave Life Sciences stock from 15 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 7 | 8 | 8 | 8 | 7 |
| Buy | 8 | 7 | 8 | 8 | 8 | 8 |
| Hold | 1 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 14 | 16 | 16 | 16 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +123.55% | Mar 2, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $29 → $27 | Buy | Maintains | $29 → $27 | +101.19% | Feb 12, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $34 → $41 | Buy | Maintains | $34 → $41 | +205.51% | Feb 5, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $40 → $43 | Strong Buy | Maintains | $40 → $43 | +220.42% | Feb 3, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $22 → $30 | Strong Buy | Maintains | $22 → $30 | +123.55% | Dec 19, 2025 |
Financial Forecast
Revenue This Year
49.89M
from 42.73M
Increased by 16.76%
Revenue Next Year
124.64M
from 49.89M
Increased by 149.85%
EPS This Year
-1.26
from -1.21
EPS Next Year
-1.07
from -1.26
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 106.1M | 301.0M | |||
| Avg | 49.9M | 124.6M | |||
| Low | n/a | 46.4M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 148.2% | 503.5% | |||
| Avg | 16.8% | 149.8% | |||
| Low | - | -6.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -1.00 | -0.23 | |||
| Avg | -1.26 | -1.07 | |||
| Low | -1.59 | -1.66 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.